Biography
Dr. Norah Terrault is a hepatologist or liver specialist who is recognized internationally for the treatment of viral hepatitis and liver transplantation. Her research includes the study of viral hepatitis and its progression and treatment, especially in liver transplant patients. Her research includes several clinical trials related to preventing and treating chronic hepatitis C and B. Her studies in this area have been presented to the American Association for the Study of Liver Diseases, the leading organization for research in liver disease.
Terrault completed medical training at the University of Alberta and specialty medical training in Internal Medicine and Gastroenterology at the University of Toronto, both in Canada. Her post-doctoral fellowship in hepatology and viral hepatitis was completed at the University of California, San Francisco while earning a concurrent master's degree in public health from the University of California at Berkeley. She joined the medical staff at UCSF Medical Center in 1997.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California, San Francisco | Post-Doc Fellow/Scholar | Medicine | 1995 |
University of Alberta | M.D. | School of Medicine | 1987 |
University of California, San Francisco | Residency | ||
University of California, San Francisco | Clinical Fellowship | Gastroenterology |
Board Certifications
American Board of Internal Medicine, Internal Medicine
American Board of Internal Medicine, Gastroenterology
Clinical Expertise
Alcoholic Liver Disease
Autoimmune Hepatitis
Benign Liver Tumors
Cirrhosis
Fulminant Hepatic Failure
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Live Donor Liver Transplantation
Liver Transplantation
Nonalcoholic Fatty Liver Disease
Pancreas Transplantation
Primary Biliary Cirrhosis
Primary Sclerosing Cholangitis
Clinical Trials
- Vitamin E Dosing Study (NCT04801849)Related Conditions: Liver Disease, Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Steatohepatitis| Start Date: | End Date:
- Nonalcoholic Fatty Liver Disease (NAFLD) Database 3 (NCT04454463)Related Conditions: Liver Disease, Nonalcoholic Fatty Liver Disease| Start Date: | End Date:
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. (NCT01804829)Related Conditions: Hepatitis C, Viruses, Hepatocellular Cancer, Liver Cancer, Hepatitis, Cirrhosis, Liver Transplant, Hepatitis A| Start Date: | End Date:
- Related Conditions: Hepatitis B, Liver Disease, Liver Transplant, Hepatitis A, Hepatitis| Start Date: | End Date:
Program Affiliations
UCSF Liver Center
In the News
Grants and Funding
- USC Cirrhosis Clinical Center | NIH | 2021-09-22 - 2026-08-31 | Role: Principal Investigator
- Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) | NIH | 2002-06-15 - 2024-06-30 | Role: Principal Investigator
- Hepatitis B Research Network (HBRN): Natural History and Treatment Studies | NIH | 2008-09-30 - 2021-05-31 | Role: Principal Investigator
- Bay Area Hepatitis C Cooperative Research Center | NIH | 2010-06-15 - 2016-05-31 | Role: Co-Investigator
- General Clinical Research Center | NIH | 1974-12-01 - 2009-03-31 | Role: Co-Investigator
- Resistance to Antiviral Therapy in Chronic Hepatitis C | NIH | 2001-08-01 - 2007-04-30 | Role: Principal Investigator
Research Narrative
My research focuses on the natural history and treatment of hepatitis C virus (HCV) and hepatitis B virus (HBV), particularly in special populations, including those undergoing liver transplantation. Work in progress addresses the natural history of post-transplant disease and specific therapies to prevent infection or modify HCV and HBV disease progression and loss of grafts from recurrent disease.
Our virological analyses are focused on characterization of viral mutations that occur in liver transplant recipients receiving antiviral therapies and assessment of the effect of these variant viruses on the natural history and severity of disease post-transplantation. Knowledge of these factors may allow improved organ allocation by identifying subsets of patients with HCV recurrence in liver grafts who would be favorable or unfavorable candidates for retransplantation.
Research Interests
Liver Injury and Repair
Hepatitis B virus (HBV)
Hepatitis C virus (HCV)
Publications
- Maternal neighbourhood-level social determinants of health and their association with paediatric hepatitis C screening among children exposed to hepatitis C in pregnancy.| | View in PubMed
- Reply: 'From NAFLD to MASLD: Promise and pitfalls of a new definition' †.| | View in PubMed
- Low frequency of HBsAg reemergence in liver transplant recipients after stopping hepatitis B immune globulin: Implications for prophylaxis protocols.| | View in PubMed
- Neighborhood-level Social Determinants of Health and Waitlist Mortality for Liver Transplantation: The Liver Outcomes and Equity Index.| | View in PubMed
- Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature.| | View in PubMed
- Peginterferon as Part of a Functional Cure Strategy for Hepatitis B: Is the Juice Worth the Squeeze?| | View in PubMed
- Reply: Recognizing the new nomenclature requires a comprehensive analysis of the prevalence, severity, and long-term outlook for SLD and subclassifications.| | View in PubMed
- Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study.| | View in PubMed
- Hepatitis C.| | View in PubMed
- National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature.| | View in PubMed
- Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women.| | View in PubMed
- Reply: NAFLD, MAFLD, or MASLD? Cut the Gordian knot with "Ludwig disease".| | View in PubMed
- HDV RNA assays: Performance characteristics, clinical utility, and challenges.| | View in PubMed
- A global action agenda for turning the tide on fatty liver disease.| | View in PubMed
- Association of nativity with survival among adults with hepatocellular carcinoma.| | View in PubMed
- Global importance of new treatment strategies to efforts to control hepatitis B virus.| | View in PubMed
- Association of Alanine Aminotransferase Flares to Hepatitis B Surface Decline During Tenofovir Alone or With Pegylated Interferon Alfa.| | View in PubMed
- Reply: People living with HIV and NAFLD and updated guidance on NAFLD screening.| | View in PubMed
- Reply: ELF in the risk stratification of NAFLD-Are the ELF thresholds suggested by the AASLD guidelines appropriate?| | View in PubMed
- National Trends in Alcohol Use, Metabolic Syndrome, and Liver Disease From 1999 to 2018.| | View in PubMed
- Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.| | View in PubMed
- Liver Transplantation 2023: Status Report, Current and Future Challenges.| | View in PubMed
- Use of HBV RNA and to predict change in serological status and disease activity in CHB.| | View in PubMed
- Population-attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi-ethnic cohort.| | View in PubMed
- Prevalence, Risk Profiles, and National Implications of Nonalcoholic Fatty Liver Disease in Pregnant Individuals.| | View in PubMed
- Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.| | View in PubMed
- Healthcare affordability and effects on mortality among adults with liver disease from 2004 to 2018 in the United States.| | View in PubMed
- Global epidemiology of cirrhosis - aetiology, trends and predictions.| | View in PubMed
- Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO-PLUS study.| | View in PubMed
- Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis.| | View in PubMed
- Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial.| | View in PubMed
- Addressing sex-based disparities in solid organ transplantation in the United States - a conference report.| | View in PubMed
- The scientific basis of combination therapy for chronic hepatitis B functional cure.| | View in PubMed
- Quantifying the Negative Impact of Fast-food Consumption on Liver Steatosis Among United States Adults With Diabetes and Obesity.| | View in PubMed
- Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial.| | View in PubMed
- Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.| | View in PubMed
- Liver transplant for alcohol-associated liver disease continues to rise 2 years into the COVID-19 pandemic especially among young adults.| | View in PubMed
- Prospective clinical trials and novel therapies in the medical management of severe alcohol-associated hepatitis.| | View in PubMed
- Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease.| | View in PubMed
- Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a U.S. population-based study.| | View in PubMed
- Reply.| | View in PubMed
- Health disparities in chronic liver disease.| | View in PubMed
- In Memoriam-Hugo R. Rosen.| | View in PubMed
- Geographic Density of Gastroenterologists Is Associated With Decreased Mortality From Alcohol-Associated Liver Disease.| | View in PubMed
- Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection.| | View in PubMed
- Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance.| | View in PubMed
- Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion.| | View in PubMed
- Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation.| | View in PubMed
- Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply.| | View in PubMed
- Breakthroughs in hepatology.| | View in PubMed
- Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission.| | View in PubMed
- Advocacy for Equity in Transplantation Access for Alcohol-Associated Liver Disease: How Research Changed Medi-Cal Policy.| | View in PubMed
- Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.| | View in PubMed
- Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis.| | View in PubMed
- Transplantation, HIV Serostatus, and Registry Data: Room for Improvement.| | View in PubMed
- Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms.| | View in PubMed
- Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD).| | View in PubMed
- Pregnancy-Associated Liver Diseases.| | View in PubMed
- Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.| | View in PubMed
- Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort.| | View in PubMed
- Discordance in categorization of acute-on-chronic liver failure in the United Network for Organ Sharing database.| | View in PubMed
- Reply.| | View in PubMed
- Food Insecurity is Associated With Mortality Among U.S. Adults With Nonalcoholic Fatty Liver Disease and Advanced Fibrosis.| | View in PubMed
- Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B.| | View in PubMed
- Medicaid expansion and variability in mortality in the USA: a national, observational cohort study.| | View in PubMed
- Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.| | View in PubMed
- Hepatic macrosteatosis in the US pediatric deceased liver donor population.| | View in PubMed
- Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.| | View in PubMed
- Diverging Incidence Trends for Hepatocellular Carcinoma in Rural and Urban Settings in the United States.| | View in PubMed
- NAFLD and Alcohol-Associated Liver Disease Will Be Responsible for Almost All New Diagnoses of Cirrhosis in Canada by 2040.| | View in PubMed
- Changes and mediators of survival disparity among Black liver transplant recipients in the United States.| | View in PubMed
- Use of Hepatitis B Virus-Positive Organs in Organ Transplantation.| | View in PubMed
- Enhanced Screening for Hepatitis D in the USA: Overcoming the Delta Blues.| | View in PubMed
- Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus.| | View in PubMed
- Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation.| | View in PubMed
- Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.| | View in PubMed
- Reply to 'Evidence against in utero transmission of hepatitis B virus'.| | View in PubMed
- Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.| | View in PubMed
- Hepatitis E Infection in a Longitudinal Cohort of Hepatitis C Virus and HCV/HIV Coinfected Persons.| | View in PubMed
- Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications.| | View in PubMed
- Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver.| | View in PubMed
- Transplanting Kidneys From Donors With Chronic Hepatitis B: Bringing Transmission Risk Closer to Zero.| | View in PubMed
- Retail Alcohol and Tobacco Sales During COVID-19.| | View in PubMed
- Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.| | View in PubMed
- Addressing Social Determinants of Liver Disease During the COVID-19 Pandemic and Beyond: A Call to Action.| | View in PubMed
- The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder.| | View in PubMed
- Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors.| | View in PubMed
- Adherence to pregnancy hepatitis B care guidelines in women and infants in the United States and evaluation of two interventions to improve care: A multicentre hospital-based study.| | View in PubMed
- Caesarean section or non-breastfeeding for prevention of MTCT-beware of sending the wrong message.| | View in PubMed
- Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.| | View in PubMed
- Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplant.| | View in PubMed
- Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.| | View in PubMed
- Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis.| | View in PubMed
- Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma.| | View in PubMed
- Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation.| | View in PubMed
- Viral hepatitis and pregnancy.| | View in PubMed
- Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH.| | View in PubMed
- Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.| | View in PubMed
- Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD.| | View in PubMed
- The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study.| | View in PubMed
- Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.| | View in PubMed
- Associations Between Reproductive and Hormone-Related Factors and Risk of Nonalcoholic Fatty Liver Disease in a Multiethnic Population.| | View in PubMed
- Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based Study.| | View in PubMed
- Letter to the Editor: Safety First: Favoring Prophylactic/Preemptive Over Delayed Treatment in D+/R- Transplants.| | View in PubMed
- Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.| | View in PubMed
- Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States.| | View in PubMed
- Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.| | View in PubMed
- Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B.| | View in PubMed
- Mortality in adults with chronic hepatitis B infection in the United States: a population-based study.| | View in PubMed
- Hepatitis C Screening Rates and Care Cascade in a Large US Insured Population, 2010-2016: Gaps to Elimination.| | View in PubMed
- Medicaid Policy and Liver Transplant for Alcohol-Associated Liver Disease.| | View in PubMed
- KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.| | View in PubMed
- DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.| | View in PubMed
- Oncogenic HBV variants and integration are present in hepatic and lymphoid cells derived from chronic HBV patients.| | View in PubMed
- Selective use of liver transplantation for severe alcohol-associated hepatitis.| | View in PubMed
- Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation.| | View in PubMed
- Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America.| | View in PubMed
- Liver transplantation as therapy for hepatocellular carcinoma.| | View in PubMed
- Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies.| | View in PubMed
- Liver Transplantation in Unauthorized Immigrants in the United States.| | View in PubMed
- Expanding the use of hepatitis C-positive donors and keeping recipient safety at the forefront.| | View in PubMed
- Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis.| | View in PubMed
- Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men.| | View in PubMed
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference.| | View in PubMed
- Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡.| | View in PubMed
- Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis.| | View in PubMed
- Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.| | View in PubMed
- Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines.| | View in PubMed
- Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.| | View in PubMed
- An Evaluation of Hepatitis C Virus Telehealth Services Serving Tribal Communities: Patterns of Usage, Evolving Needs, and Barriers.| | View in PubMed
- Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.| | View in PubMed
- Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.| | View in PubMed
- Superior Wait-List Outcomes in Patients with Alcohol-Associated Liver Disease Compared With Other Indications for Liver Transplantation.| | View in PubMed
- Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.| | View in PubMed
- Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality.| | View in PubMed
- Outcomes of liver transplantation for acute fatty liver disease of pregnancy.| | View in PubMed
- Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.| | View in PubMed
- Sex Hormone-Binding Globulin Levels in Young Men Are Associated With Nonalcoholic Fatty Liver Disease in Midlife.| | View in PubMed
- Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B.| | View in PubMed
- Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.| | View in PubMed
- Novel NS5B Resistance-Associated Substitution Emerges Under Failing Sofosbuvir/Ledipasvir Therapy.| | View in PubMed
- Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database.| | View in PubMed
- Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise.| | View in PubMed
- Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.| | View in PubMed
- Outcomes of Sleeve Gastrectomy in Obese Liver Transplant Candidates.| | View in PubMed
- Predicting Low Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The Sustained Alcohol Use Post-Liver Transplant Score.| | View in PubMed
- National Trends and Long-term Outcomes of Liver Transplant for Alcohol-Associated Liver Disease in the United States.| | View in PubMed
- Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis.| | View in PubMed
- Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection.| | View in PubMed
- Prior Bariatric Surgery in Liver Transplant Candidates: Unforeseen Consequences?| | View in PubMed
- Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.| | View in PubMed
- Reply.| | View in PubMed
- Hepatitis C elimination: challenges with under-diagnosis and under-treatment.| | View in PubMed
- HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition.| | View in PubMed
- Return to Alcohol Use After Liver Transplant: Patterns and Surveillance.| | View in PubMed
- Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B: One of These Things Is Not Like the Other.| | View in PubMed
- Use of hepatitis C viraemic organs in kidney transplantation: a need to hit the pause button?| | View in PubMed
- Viral Hepatitis and Hepatocellular Carcinoma.| | View in PubMed
- Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease.| | View in PubMed
- New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection.| | View in PubMed
- Reply.| | View in PubMed
- Care of Patients Following Cure of Hepatitis C Virus Infection.| | View in PubMed
- Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women.| | View in PubMed
- Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.| | View in PubMed
- Evaluating Women's Preferences for Hepatitis C Treatment During Pregnancy.| | View in PubMed
- Reply.| | View in PubMed
- Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis.| | View in PubMed
- Is Low Level Viremia Acceptable During Antiviral Therapy of Patients With HBV Infection and Decompensated Cirrhosis?| | View in PubMed
- Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy.| | View in PubMed
- Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.| | View in PubMed
- Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy.| | View in PubMed
- A changing landscape of liver transplantation: King HCV is dethroned, ALD and NAFLD take over!| | View in PubMed
- Outcomes of antiviral treatment in hepatitis C virus liver transplant patients off immunosuppression in the direct acting antivirals era: A case series.| | View in PubMed
- Tenofovir to Prevent Perinatal Transmission of Hepatitis B.| | View in PubMed
- Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.| | View in PubMed
- Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout.| | View in PubMed
- Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.| | View in PubMed
- Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.| | View in PubMed
- Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.| | View in PubMed
- Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus.| | View in PubMed
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.| | View in PubMed
- Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.| | View in PubMed
- Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.| | View in PubMed
- Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.| | View in PubMed
- The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome.| | View in PubMed
- Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.| | View in PubMed
- Immune tolerant HBV and HCC: time to revise our tolerance levels for therapy?| | View in PubMed
- Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis.| | View in PubMed
- Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.| | View in PubMed
- Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study.| | View in PubMed
- Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success.| | View in PubMed
- Body mass index trajectories in young adulthood predict non-alcoholic fatty liver disease in middle age: The CARDIA cohort study.| | View in PubMed
- Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.| | View in PubMed
- Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.| | View in PubMed
- Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.| | View in PubMed
- Management of hepatitis B in special populations.| | View in PubMed
- International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates.| | View in PubMed
- International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients.| | View in PubMed
- Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.| | View in PubMed
- Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.| | View in PubMed
- Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife.| | View in PubMed
- Hepatitis C virus infection.| | View in PubMed
- Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.| | View in PubMed
- Perioperative Ledipasvir-Sofosbuvir for HCV in Liver-Transplant Recipients.| | View in PubMed
- Estrategias para el tratamiento de pacientes con infecciĂłn por el virus de la hepatitis B sometidos a terapia inmunomoduladora: Âżes suficiente usar lamivudina?| | View in PubMed
- Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.| | View in PubMed
- Management of the patient with SVR.| | View in PubMed
- Real-World Experiences with Tenofovir Disoproxil Fumarate: Is this the "B-Ticket"?| | View in PubMed
- Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response.| | View in PubMed
- Patient Sex, Reproductive Status, and Synthetic Hormone Use Associate With Histologic Severity of Nonalcoholic Steatohepatitis.| | View in PubMed
- Key donor factors associated with graft loss among liver transplant recipients with human immunodeficiency virus.| | View in PubMed
- Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant.| | View in PubMed
- Hepatitis B surface antigen loss: Not all that we hoped it would be.| | View in PubMed
- Women with Cirrhosis: Prevalence, Natural History, and Management.| | View in PubMed
- Treatment of chronic hepatitis C in patients with cirrhosis.| | View in PubMed
- Perspectives on treating hepatitis C infection in the liver transplantation setting.| | View in PubMed
- Report from the International Conference on Viral Hepatitis (ICVH), San Francisco, March 2016.| | View in PubMed
- Response to clinical assessments of health status as a potential marker to identify patients who are too sick to undergo transplantation.| | View in PubMed
- The changing 'face' of wait-listed patients in the USA.| | View in PubMed
- Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.| | View in PubMed
- Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease.| | View in PubMed
- Emerging Therapies for Nonalcoholic Fatty Liver Disease.| | View in PubMed
- Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network.| | View in PubMed
- Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.| | View in PubMed
- AASLD guidelines for treatment of chronic hepatitis B.| | View in PubMed
- Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.| | View in PubMed
- Diabetes and prediabetes in patients with hepatitis B residing in North America.| | View in PubMed
- Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.| | View in PubMed
- Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.| | View in PubMed
- New Therapies, Evidence, and Guidance in Hepatitis C Management: Expert Practices and Insights from an Educational Symposium at the AMCP 27th Annual Meeting Expo.| | View in PubMed
- Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.| | View in PubMed
- The corrected donor age for hepatitis C virus-infected liver transplant recipients.| | View in PubMed
- Optimizing the pre-referral workup for gastroenterology and hepatology specialty care: consensus using the Delphi method.| | View in PubMed
- Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis.| | View in PubMed
- Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant Patients.| | View in PubMed
- Severe Cholestatic Hepatitis C in Transplant Recipients: No Longer a Threat to Graft Survival.| | View in PubMed
- Difficult-to-cure populations with chronic hepatitis C: Vanishing in the direct-acting antiviral era?| | View in PubMed
- Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.| | View in PubMed
- Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander?| | View in PubMed
- Hepatitis C genotype influences post-liver transplant outcomes.| | View in PubMed
- Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.| | View in PubMed
- Management strategies for hepatitis B-infected patients undergoing immunomodulatory therapy: Is lamivudine enough?| | View in PubMed
- Total 25(OH) vitamin D, free 25(OH) vitamin D and markers of bone turnover in cirrhotics with and without synthetic dysfunction.| | View in PubMed
- Human immunodeficiency virus and liver transplantation: Hepatitis C is the last hurdle.| | View in PubMed
- High Rate of Hospital Admissions Among Patients with Cirrhosis Seeking Care in US Emergency Departments.| | View in PubMed
- Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation.| | View in PubMed
- Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?| | View in PubMed
- Sofosbuvir, simeprevir, and ribavirin for the treatment of hepatitis C virus recurrence in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients.| | View in PubMed
- Reply: To PMID 25045002.| | View in PubMed
- Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C.| | View in PubMed
- Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective.| | View in PubMed
- Reply to Prediction of hepatocellular carcinoma: using a complex risk model or assisting for smoking cessation?| | View in PubMed
- Outcomes in liver transplantation: does sex matter?| | View in PubMed
- An interferon-free antiviral regimen for HCV after liver transplantation.| | View in PubMed
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.| | View in PubMed
- Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update.| | View in PubMed
- Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.| | View in PubMed
- Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.| | View in PubMed
- Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.| | View in PubMed
- Advances in therapy for HIV/hepatitis C virus-coinfected patients in the liver transplant setting.| | View in PubMed
- Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.| | View in PubMed
- Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.| | View in PubMed
- Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure.| | View in PubMed
- Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.| | View in PubMed
- Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals - authors' reply.| | View in PubMed
- Ending vertical transmission of hepatitis B: the third trimester intervention.| | View in PubMed
- A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.| | View in PubMed
- Characteristics and management of patients with chronic hepatitis B in an integrated care setting.| | View in PubMed
- Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.| | View in PubMed
- Sexual transmission of hepatitis C: A rare event among heterosexual couples.| | View in PubMed
- Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.| | View in PubMed
- Solid organ transplants in HIV-infected patients.| | View in PubMed
- Donor Risk Index for African American liver transplant recipients with hepatitis C virus.| | View in PubMed
- Reply: To PMID 23175457.| | View in PubMed
- Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study.| | View in PubMed
- Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naĂŻve patients with hepatitis C virus genotype 1 infection.| | View in PubMed
- Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era?| | View in PubMed
- Reply: To PMID 23281277.| | View in PubMed
- Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study.| | View in PubMed
- A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation.| | View in PubMed
- Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.| | View in PubMed
- Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.| | View in PubMed
- Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.| | View in PubMed
- Acute hepatitis C in an HIV-infected patient: a case report and review of literature.| | View in PubMed
- Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.| | View in PubMed
- Hepatitis C virus: a critical appraisal of new approaches to therapy.| | View in PubMed
- Liver transplantation in the setting of chronic HCV.| | View in PubMed
- Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies.| | View in PubMed
- Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.| | View in PubMed
- Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.| | View in PubMed
- Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.| | View in PubMed
- Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.| | View in PubMed
- The option of HBIG-free prophylaxis against recurrent HBV.| | View in PubMed
- Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.| | View in PubMed
- Multidisciplinary management of hepatocellular carcinoma.| | View in PubMed
- Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.| | View in PubMed
- Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.| | View in PubMed
- Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy.| | View in PubMed
- Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.| | View in PubMed
- Progression of biopsy-measured liver fibrosis in untreated patients with hepatitis C infection: non-Markov multistate model analysis.| | View in PubMed
- PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.| | View in PubMed
- Individualizing hepatitis B infection prophylaxis in liver transplant recipients.| | View in PubMed
- Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study.| | View in PubMed
- Management of posttransplant hepatitis C infection.| | View in PubMed
- Viral hepatitis and inflammatory bowel disease.| | View in PubMed
- Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.| | View in PubMed
- Telaprevir for previously treated chronic HCV infection.| | View in PubMed
- The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance.| | View in PubMed
- Understanding the natural history of chronic HBV and HCV infections.| | View in PubMed
- Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.| | View in PubMed
- Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant.| | View in PubMed
- A glimpse of future hepatitis C virus treatment paradigms.| | View in PubMed
- Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).| | View in PubMed
- Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study.| | View in PubMed
- Prevalence and predictors of hepatic steatosis in adults with newly diagnosed chronic liver disease due to hepatitis C.| | View in PubMed
- Trends in waiting list registration for liver transplantation for viral hepatitis in the United States.| | View in PubMed
- Older donors: mounting risks for the hepatitis C-infected liver transplant recipient?| | View in PubMed
- Is recurrent hepatitis C worse with living donors?| | View in PubMed
- Management of patients co-infected with HBV and HCV.| | View in PubMed
- Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients.| | View in PubMed
- Benefits and risks of combination therapy for hepatitis B.| | View in PubMed
- Transplant tourism to China: the impact on domestic patient-care decisions.| | View in PubMed
- Hepatitis C virus: a critical appraisal of approaches to therapy.| | View in PubMed
- Hepatitis C therapy before and after liver transplantation.| | View in PubMed
- Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.| | View in PubMed
- Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.| | View in PubMed
- Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.| | View in PubMed
- The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.| | View in PubMed
- Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy.| | View in PubMed
- Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.| | View in PubMed
- Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment.| | View in PubMed
- Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.| | View in PubMed
- Are HIV-infected patients candidates for liver transplantation?| | View in PubMed
- Cognitive impairment in hepatitis C patients on antiviral therapy.| | View in PubMed
- Influence of cannabis use on severity of hepatitis C disease.| | View in PubMed
- Management of hepatitis B in liver transplant recipients.| | View in PubMed
- Outcomes of donor evaluation in adult-to-adult living donor liver transplantation.| | View in PubMed
- Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy.| | View in PubMed
- The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.| | View in PubMed
- Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.| | View in PubMed
- Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?| | View in PubMed
- Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.| | View in PubMed
- The changing epidemiology and natural history of hepatitis C virus infection.| | View in PubMed
- Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.| | View in PubMed
- Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection.| | View in PubMed
- De novo malignancies following liver transplantation: a case-control study with long-term follow-up.| | View in PubMed
- Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.| | View in PubMed
- Treating hepatitis C infection in liver transplant recipients.| | View in PubMed
- Evidence-based incorporation of serum sodium concentration into MELD.| | View in PubMed
- Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation.| | View in PubMed
- Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.| | View in PubMed
- Management of recurrent hepatitis C in liver transplant recipients.| | View in PubMed
- Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years.| | View in PubMed
- Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.| | View in PubMed
- Treatment of recurrent hepatitis C in liver transplant recipients.| | View in PubMed
- Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy.| | View in PubMed
- A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients.| | View in PubMed
- Treatment of recurrent hepatitis C after liver transplantation.| | View in PubMed
- Management of the hepatitis B virus in the liver transplantation setting: a European and an American perspective.| | View in PubMed
- Update on chronic hepatitis C.| | View in PubMed
- Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease.| | View in PubMed
- Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.| | View in PubMed
- Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.| | View in PubMed
- Serum sodium predicts mortality in patients listed for liver transplantation.| | View in PubMed
- Chronic Hepatitis B.| | View in PubMed
- Antiviral therapy in patients with chronic hepatitis B and cirrhosis.| | View in PubMed
- Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.| | View in PubMed
- Hepatitis C virus and lichen planus: a review.| | View in PubMed
- Longitudinal effect of antiretroviral therapy on markers of hepatic toxicity: impact of hepatitis C coinfection.| | View in PubMed
- New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.| | View in PubMed
- Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).| | View in PubMed
- Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.| | View in PubMed
- Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.| | View in PubMed
- Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation.| | View in PubMed
- Kidney and liver transplantation in HIV-infected patients: case presentations and review.| | View in PubMed
- Prevalence of HBV precore/core promoter variants in the United States.| | View in PubMed
- Hepatitis B immune globulin preparations and use in liver transplantation.| | View in PubMed
- Hepatitis B virus genotypes in the United States: results of a nationwide study.| | View in PubMed
- Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.| | View in PubMed
- A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents.| | View in PubMed
- Should HCV-related cirrhosis be a contraindication for retransplantation?| | View in PubMed
- Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation.| | View in PubMed
- Burden of liver disease in the United States: summary of a workshop.| | View in PubMed
- Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties.| | View in PubMed
- Chronic Hepatitis B.| | View in PubMed